Journée Scientifique 2026

  • 35th Annual Meeting
  • Wednesday, November 18, 2026
  • Palais des Congrès de Paris
  • 2 place de la Porte Maillot, 75017 Paris
  •  
  • “Rewiring identity: androgen receptor networks and plasticity in prostate cancer resistance”
  •  
  •  
  • 8:15 a.m
  • Registration (Ground floor)
  •  
  •  
  • 9:00 a.m
  • Welcome
  • Arnauld Villers, ARTP President
  •  
  •  
  • 9:05 a.m
  • Session I : ARTP Grant Recipients
  • Chairs :
  •  
  • Leyre BRIZUELA-MADRID (ICBMS CNRS UMR 5246, Villeurbanne)
  • 'Exosomal phospholipase D2 as a Predictive Biomarker of Chemotherapy Efficacy in Prostate Cancer (EXOPRED)'
  •  
  • Pascal PERALDI (C3M, Inserm U1065, Nice)
  • 'Discovery of novel eIF5A inhibitors to target prostate cancer'
  •  
  • 9:45 a.m
  • Coffee Break & Visit of Exhibition Booths
  •  
  •  
  • 10:15 a.m
  • Session II : Phenotypic plasticity as a mechanism of resistance to targeted therapy in cancer
  • Chairs :
  •  
  • Alfonso URBANUCCI (Oslo University Hospital, Norway ; Tampere University, Finland)
  • 'Resolving prostate cancer mechanisms of treatment resistance at spatial level and single cell resolution'
  •  
  • Vincent GOFFIN (Institut Necker Enfants Malades, Paris)
  • 'Targeting pre-existing club-like cells in prostate cancer potentiates androgen deprivation therapy'
  •  
  • Nathalie MAZURE (C3M, Inserm U1065, Nice)
  • 'Primary Cilium Forces Neuroendocrine Shift in Prostate Cancer through YAP1 Repression and Reduced Mitochondrial Activity'
  •  
  •  
  • 12:00 p.m
  • Lunch
  •  
  •  
  • 1:15 p.m
  • Session III : Clinical Session
  • Chairs :
  •  
  • Carole HELISSEY (Hôpital Paris Saint-Joseph, Paris)
  • ‘Advanced Prostate Cancer: Bridging Clinical and Molecular Insights — A Clinician's Perspective
  •  
  • Hélène BLONS (Hôpital européen Georges-Pompidou, Paris)
  • ‘Molecular characterization of metastatic prostate cancer : how next-generation sequencing supports precision oncology’
  •  
  • Aude BESSON (Institut Bergonié, Bordeaux)
  • 'Prognostic value of tertiary lymphoid structures in metastatic prostate cancer'
  •  
  •  
  • 2:15 p.m
  • Coffee Break & Visit of Exhibition Booths
  •  
  •  
  • 2:30 p.m

  • Session IV : Androgen receptor signaling, co-regulators and plasticity in prostate cancer progression

  • Chairs :
  •  
  • Jean-Philippe THEURILLAT (Institute of Oncology Research, Bellinzona, Switzerland)
  • 'Targeting prostate cancer progression through AR signaling enablers'
  •  
  • Kirsi KETOLA (University of Eastern Finland, Kuopio, Finland)
  • 'Androgen receptor signaling and beyond: microenvironmental and developmental drivers of cellular plasticity in prostate cancer'
  •  
  • 3:30 p.m
  • Session V : Poster Session
  • Chairs : Edith Bonnelye,
  • Les candidats au Prix du Meilleur Poster auront 5 minutes pour présenter leur poster/Candidates for the Best Poster Award will have 5 minutes to present their poster.
  •  
  •  
  • 5:00 p.m
  • Session VI : 2025 ARTP Poster Competition Awardees
  • Chairs : Edith Bonnelye,
  •  
  • Martina de SOUSA (iGRED, Clermont-Ferrand)
  • 'nvestigating the Role of the Scavenger Receptor Class B Type 1 in advanced Prostate Cancer'
  • Giudetta DELLA CORTE (Institut Curie, Paris)
  • 'Androgen Receptor-RNA and Protein Interactome in Cell Plasticity and Onset of Castration Resistant Prostate Cancer'
  • Aaron MADDEN (University of Piemont Orientale, Novara, Italy)
  • 'Linking ACSS2 Structure, Enzyme Activity, and Drug Repurposing to Target Lipid Metabolism in Prostate Cancer'
  •  
  • 5:30 p.m
  • Assemblée Générale ARTP
  • Poster Prize Distribution
  • Arnauld Villers, ARTP President
  • Olivier Cuvillier, ARTP Treasurer
  •  
  • 5:45 p.m
  • End of the meeting